GENERAL INCEPTION — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Simbiosyssimbiosys.comin 𝕏Jan 2025SEC filingmedium confidence

Simbiosys develops AI-powered 3D visualization and diagnostic technology that converts 2D medical imaging into interactive 3D digital tumor models to support surgical planning and patient treatment.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

Joseph Peterson(Executive Officer, Director)Stacey Stevens(Executive Officer, Director)John A Cole(Executive Officer)

BoardLucy Coassin(Director)Ronnie Andrews(Director)

Board seatVikram Chaudhery· per SEC Form D · $8M raise · filed Jan 2025

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.